APP and cerebral amyloid angiopathy: Inhibiting NOX with the naturally occurring compound, apocynin, or genetic deletion of gp91phox in mice (Tg2576) overexpressing mutant amyloid precursor protein (APP), attenuates cerebral amyloid angiopathy (CAA) [115,116].